Neuroendocrine Tumors of the Pancreas

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Neuroendocrine tumors of the pancreas are the second most common maLignant neoplasm of the pancreas. While they are less aggressive than ductal adenocarcinoma, they are often discovered at advanced cLinical stage, and overall survival is only 45% at 10 years. This tumor has recently received increased attention as pubLic figures such as Steve Jobs, cofounder of Apple Computer Corporation have succumbed to the disease. This article focuses on the cLinical and pathologic features of pancreatic neuroendocrine tumors, including diagnosis, classification, and treatment. In addition, genetic syndromes defined by or associated with the development of pancreatic neuroendocrine tumors are discussed. Finally, our current understanding of the molecular mechanisms underlying pancreatic neuroendocrine tumorigenesis is explored, and areas for future research are highLighted.

Original languageEnglish (US)
Title of host publicationPathobiology of Human Disease
Subtitle of host publicationA Dynamic Encyclopedia of Disease Mechanisms
PublisherElsevier Inc.
Pages2284-2292
Number of pages9
ISBN (Electronic)9780123864567
ISBN (Print)9780123864574
DOIs
StatePublished - Jan 1 2014
Externally publishedYes

Fingerprint

Neuroendocrine Tumors
Pancreas
Malus
Pancreatic Neoplasms
Carcinogenesis
Adenocarcinoma
Neoplasms
Therapeutics

Keywords

  • ATRX
  • Carcinoid
  • Chromogranin
  • DAXX
  • Gastrinoma
  • Glucagonoma
  • InsuLinoma
  • MTOR
  • Multiple endocrine neoplasia
  • Neuroendocrine
  • Neurofibromatosis
  • Pancreas
  • Somatostatin
  • Synaptophysin
  • Tuberous sclerosis
  • Von Hippel-Lindau

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Matsukuma, K. (2014). Neuroendocrine Tumors of the Pancreas. In Pathobiology of Human Disease: A Dynamic Encyclopedia of Disease Mechanisms (pp. 2284-2292). Elsevier Inc.. https://doi.org/10.1016/B978-0-12-386456-7.04907-8

Neuroendocrine Tumors of the Pancreas. / Matsukuma, Karen.

Pathobiology of Human Disease: A Dynamic Encyclopedia of Disease Mechanisms. Elsevier Inc., 2014. p. 2284-2292.

Research output: Chapter in Book/Report/Conference proceedingChapter

Matsukuma, K 2014, Neuroendocrine Tumors of the Pancreas. in Pathobiology of Human Disease: A Dynamic Encyclopedia of Disease Mechanisms. Elsevier Inc., pp. 2284-2292. https://doi.org/10.1016/B978-0-12-386456-7.04907-8
Matsukuma K. Neuroendocrine Tumors of the Pancreas. In Pathobiology of Human Disease: A Dynamic Encyclopedia of Disease Mechanisms. Elsevier Inc. 2014. p. 2284-2292 https://doi.org/10.1016/B978-0-12-386456-7.04907-8
Matsukuma, Karen. / Neuroendocrine Tumors of the Pancreas. Pathobiology of Human Disease: A Dynamic Encyclopedia of Disease Mechanisms. Elsevier Inc., 2014. pp. 2284-2292
@inbook{aff45df624bf45948fc78cf9a6dfc631,
title = "Neuroendocrine Tumors of the Pancreas",
abstract = "Neuroendocrine tumors of the pancreas are the second most common maLignant neoplasm of the pancreas. While they are less aggressive than ductal adenocarcinoma, they are often discovered at advanced cLinical stage, and overall survival is only 45{\%} at 10 years. This tumor has recently received increased attention as pubLic figures such as Steve Jobs, cofounder of Apple Computer Corporation have succumbed to the disease. This article focuses on the cLinical and pathologic features of pancreatic neuroendocrine tumors, including diagnosis, classification, and treatment. In addition, genetic syndromes defined by or associated with the development of pancreatic neuroendocrine tumors are discussed. Finally, our current understanding of the molecular mechanisms underlying pancreatic neuroendocrine tumorigenesis is explored, and areas for future research are highLighted.",
keywords = "ATRX, Carcinoid, Chromogranin, DAXX, Gastrinoma, Glucagonoma, InsuLinoma, MTOR, Multiple endocrine neoplasia, Neuroendocrine, Neurofibromatosis, Pancreas, Somatostatin, Synaptophysin, Tuberous sclerosis, Von Hippel-Lindau",
author = "Karen Matsukuma",
year = "2014",
month = "1",
day = "1",
doi = "10.1016/B978-0-12-386456-7.04907-8",
language = "English (US)",
isbn = "9780123864574",
pages = "2284--2292",
booktitle = "Pathobiology of Human Disease",
publisher = "Elsevier Inc.",

}

TY - CHAP

T1 - Neuroendocrine Tumors of the Pancreas

AU - Matsukuma, Karen

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Neuroendocrine tumors of the pancreas are the second most common maLignant neoplasm of the pancreas. While they are less aggressive than ductal adenocarcinoma, they are often discovered at advanced cLinical stage, and overall survival is only 45% at 10 years. This tumor has recently received increased attention as pubLic figures such as Steve Jobs, cofounder of Apple Computer Corporation have succumbed to the disease. This article focuses on the cLinical and pathologic features of pancreatic neuroendocrine tumors, including diagnosis, classification, and treatment. In addition, genetic syndromes defined by or associated with the development of pancreatic neuroendocrine tumors are discussed. Finally, our current understanding of the molecular mechanisms underlying pancreatic neuroendocrine tumorigenesis is explored, and areas for future research are highLighted.

AB - Neuroendocrine tumors of the pancreas are the second most common maLignant neoplasm of the pancreas. While they are less aggressive than ductal adenocarcinoma, they are often discovered at advanced cLinical stage, and overall survival is only 45% at 10 years. This tumor has recently received increased attention as pubLic figures such as Steve Jobs, cofounder of Apple Computer Corporation have succumbed to the disease. This article focuses on the cLinical and pathologic features of pancreatic neuroendocrine tumors, including diagnosis, classification, and treatment. In addition, genetic syndromes defined by or associated with the development of pancreatic neuroendocrine tumors are discussed. Finally, our current understanding of the molecular mechanisms underlying pancreatic neuroendocrine tumorigenesis is explored, and areas for future research are highLighted.

KW - ATRX

KW - Carcinoid

KW - Chromogranin

KW - DAXX

KW - Gastrinoma

KW - Glucagonoma

KW - InsuLinoma

KW - MTOR

KW - Multiple endocrine neoplasia

KW - Neuroendocrine

KW - Neurofibromatosis

KW - Pancreas

KW - Somatostatin

KW - Synaptophysin

KW - Tuberous sclerosis

KW - Von Hippel-Lindau

UR - http://www.scopus.com/inward/record.url?scp=85043301409&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85043301409&partnerID=8YFLogxK

U2 - 10.1016/B978-0-12-386456-7.04907-8

DO - 10.1016/B978-0-12-386456-7.04907-8

M3 - Chapter

AN - SCOPUS:85043301409

SN - 9780123864574

SP - 2284

EP - 2292

BT - Pathobiology of Human Disease

PB - Elsevier Inc.

ER -